103. Kiyosawa K, Sadeyama T, Tanaka E, et al. Interrelationship of blood transfusion associated hepatitis C. N Eng J Med 1995;332:14631466
104. Yano M, Yatsuhashi H, Inoue O, et al. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993;34:13-16
105. Seeff LB, BuskeIl-Bales Z, Wright EC, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. N Eng J Med. 1992;327: 1906-1911
106. Seeff LB, Miller RN, Rcabkin ES, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105-111
107. Shakil AO, Conry-Cantilena C, Alter RJ, et al. Volunteer blood donors with antibody to hepatitis C virus Clinical, biochemical, virologic and histologic features. Ann Intern Med 1995;123:330-337
108. Niderau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C:Results of a large, prospective cohort study. Hepatology 1998;28:1687-1695
109. Muller R. The natural history of hepatitis C: Clinical experiences J Hepatol 1996;24:52
110. Vogt M, Lang T, Frösner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Eng J Med 1999;341:866-870
111. Gordon SC, Eloway RS, Long JC, et al. The pathology of hepatitis C as a function of mode of transmission. Blood transfusion versus intravenous drug use. Hepatology 1993;18:1338-1343
112. Davis GL, Lau JYN. Factors predictive of a beneficial respone to theparpy of hepatitis C Hepatology 1997;26:122
63



71. SAYFAYA BENZER SAYFALAR

tabs_sener_yagiz_191898 - Sayfa
...


71. SAYFA ICERIGI

103. Kiyosawa K, Sadeyama T, Tanaka E, et al. Interrelationship of blood transfusion associated hepatitis C. N Eng J Med 1995;332:14631466
104. Yano M, Yatsuhashi H, Inoue O, et al. Epidemiology and long term prognosis of hepatitis C virus infection in Japan. Gut 1993;34:13-16
105. Seeff LB, BuskeIl-Bales Z, Wright EC, et al. Long-term mortality after transfusion associated non-A, non-B hepatitis. N Eng J Med. 1992;327: 1906-1911
106. Seeff LB, Miller RN, Rcabkin ES, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000; 132: 105-111
107. Shakil AO, Conry-Cantilena C, Alter RJ, et al. Volunteer blood donors with antibody to hepatitis C virus Clinical, biochemical, virologic and histologic features. Ann Intern Med 1995;123:330-337
108. Niderau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C:Results of a large, prospective cohort study. Hepatology 1998;28:1687-1695
109. Muller R. The natural history of hepatitis C: Clinical experiences J Hepatol 1996;24:52
110. Vogt M, Lang T, Frösner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Eng J Med 1999;341:866-870
111. Gordon SC, Eloway RS, Long JC, et al. The pathology of hepatitis C as a function of mode of transmission. Blood transfusion versus intravenous drug use. Hepatology 1993;18:1338-1343
112. Davis GL, Lau JYN. Factors predictive of a beneficial respone to theparpy of hepatitis C Hepatology 1997;26:122
63

İlgili Kaynaklar







single.php